EUVIMEDEUVIMED entdecken
EditorialKommentar

3D printing – an alternative strategy for pediatric medicines

Alice P McCloskey, Louise Bracken, Nicola Vasey, Touraj Ehtezazi

Expert Review of Clinical Pharmacology · 2023

DOI: 10.1080/17512433.2023.2233416 ↗

Kurz gefasst

Editorial in der Zeitschrift Expert Review of Clinical Pharmacology, 2023. Verfasst von Alice P McCloskey und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University. Hauptthemen laut MEDLINE: Technology, Pharmaceutical, Printing, Three-Dimensional. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Solid oral dosage forms (SODFs) are widely accepted by society; however, their perceived ease of swallowability varies. Patients of all ages, and up to 54% of children, struggle to take a SODF without difficulty [1,2]. This often results in patients manipulating SODFs to aid swallowing, e.g. by crushing, dispersing, mixing with food, or if discussed with a healthcare professional, switching to a liquid formulation. These present further challenges with palatability issues affecting medication adherence and therapeutic outcomes, or indeed if a liquid alternative is unavailable, the necessity to source unlicensed specials or pharmaceutical compounding (extemporaneous preparation). Three-dimensional (3D) printing offers great potential to overcome these challenges and creates medicines to meet specific patient needs. It allows the precise generation of solid objects layer-by-layer of a desired shape from a digital model and using computer-aided design [3]. There is thus a total freedom of form and design. It has a range of applications and is increasingly being explored in the design of novel medical devices for surgical insertion and pharmaceutical dosage forms –the focus of this article. Printer, starting materials, and printing technique are selected according to the desired end-product application. To date, 3Dprinting of medicines has occurred in pharmaceutical factories, but due to the printers’ small sizes, there is a potential for printing in healthcare settings [4]. There are several methods used to print SODFs including those aimed at children – inkjet and extrusionbased printing systems are commonly used and outlined briefly below. Serrano et al. compare the techniques currently being explored in further detail in their recent review paper [5]. Inkjet printing involves the organized placing of liquid droplets in a Drop-on-Powder or Drop-on-Drop approach [3,6]. In the Drop-on-Powder method, the droplets are a binder or other liquid. Products manufactured using this method are highly porous and friable with associated and tailorable dissolution profiles. In Drop-on-Drop deposition, the droplets are the actual building material. This is a trickier process to control, but end products have a higher resolution. Extrusion printing on the other hand involves the ejection of semi-solid material through a nozzle and the building up of successive layers. Fused deposition modeling is a common extrusion method used to generate SODFs that uses thermoplastic solid filaments as starting materials. These either have the drug incorporated already or are modified to include the drug using hot melt extrusion. The filaments are molten, extruded, and then solidified on deposition. Pressureassisted microsyringes are an alternative extrusion method, where the semi-solid product is extruded by a pressurized air piston and is then dried. This is a less favorable extrusion approach as solvents are often involved raising toxicity concerns and product resolution is low (Figure 1). In terms of pharmaceutical dosage forms, most work has focused on design and exploration of those for oral administration – a considered ‘patient-friendly’ route. Work to date encompasses primarily SODFs that require swallowing whole, e.g. tablets and mini tablets, with an increasing interest in designing alternative oral formulations, e.g. oral films and chewables. The Food and Drug Administration (FDA) approved the first 3D-printed tablet (Spritam®) in 2015 produced using the Drop-on-Powder approach [7]. This tablet containing levetiracetam is porous in design adopting ZipDose® Technology that facilitates tablet disintegration when the patient drinks some liquid. It has paved the way for novel 3D-printed formulations to treat epilepsy that can be adopted to include almost any active pharmaceutical ingredient (API) to manage other conditions in patients of all ages, but pediatrics is of particular interest to the authors. The authors believe that polymer-based 3D-printed products are perhaps most applicable for pediatric use due to their ease of disintegration in the oral cavity, chewability (avoiding the requirement to swallow the dosage form whole), facility to incorporate coloring, or, if required, flavoring by adding a layer of taste-masking agent on the core formulation to mask bitter APIs [8]. We have created such a product as shown in Figure 2 (unpublished data) – a 3D-printed gummy bear incorporating a notoriously foul-tasting antibiotic in its liquid form-ciprofloxacin, demonstrating the possibility of this technique for pediatric application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technology, PharmaceuticalPrinting, Three-DimensionalChildHumansDosage Forms

Stichwörter der Autor:innen

3D printingchildrenmedication adherencemedicinespediatricssolid oral dosage forms

Substanzen

Dosage Forms

Autor:innen und Institutionen

  • School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University.
  • Paediatric Medicines Research Unit, Alder Hey Children's NHS Foundation Trust Liverpool.
  • The Great North Children's Hospital Newcastle-Upon-Tyne.

Zitieren

APA

McCloskey, A. P., Bracken, L., Vasey, N., & Ehtezazi, T. (2023). 3D printing – an alternative strategy for pediatric medicines. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2023.2233416

Vancouver

McCloskey AP, Bracken L, Vasey N, Ehtezazi T. 3D printing – an alternative strategy for pediatric medicines. Expert Review of Clinical Pharmacology. 2023. doi:10.1080/17512433.2023.2233416

BibTeX
@article{McCloskey2023,
  author = {McCloskey, Alice P and Bracken, Louise and Vasey, Nicola and Ehtezazi, Touraj},
  title = {3D printing – an alternative strategy for pediatric medicines},
  journal = {Expert Review of Clinical Pharmacology},
  year = {2023},
  doi = {10.1080/17512433.2023.2233416}
}
Kostenlos starten →